Lois Privor-Dumm
Biographic Data
| ID | 229247 |
|---|---|
| NAME | Lois Privor-Dumm |
| GIVEN NAMES | Lois |
| FAMILY NAME | Privor-Dumm |
| SIGNATURE | PRIVOR-DUMM L |
| AFFILIATIONS | Johns Hopkins University |
| ORCID | 0000-0001-9807-2544 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 6 |
| AUTHOR COUNT | 7 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Faith and Flu
Flu vaccination disparities persist among Black adults in the United States, highlighting the need for culturally tailored vaccination promotion strategies. A cross-sectional survey was administered to 159 members of a faith-based health alliance to examine flu vaccine uptake and related influences. Seventy-four percent reported receiving the flu vaccine. Vaccination was associated with older age, health insurance coverage, proactive health behav…
Building and Sustaining Flu Vaccine Acceptance and Trust in the Black Community through Partnerships with Churches, Salons, and Barbershops
Despite the benefits of flu vaccines, Black adults continue to experience lower vaccination rates in the United States. Contributing factors include lack of access to health care and trusted information about vaccines. The National Minority Quality Forum's Center for Sustainable Health Care Quality and Equity collaborated with church pastors, barbers, and hair stylists to disseminate a survey to their communities to assess barriers/facilitators t…
Vaccine access, equity and justice
Although significant progress has been made in achieving goals for COVID-19 vaccine access, the quest for equity and justice remains an unfinished agenda. Vaccine nationalism has prompted calls for new approaches to achieve equitable access and justice not only for vaccines but also for vaccination. This includes ensuring country and community participation in global discussions and that local needs to strengthen health systems, address issues re…
Covid-19 vaccines and the pandemic
Through the experiences gained by accelerating new vaccines for both Ebola virus infection and COVID-19 in a public health emergency, vaccine development has benefited from a ‘multiple shots on goal’ approach to new vaccine targets. This approach embraces simultaneous development of candidates with differing technologies, including, when feasible, vesicular stomatitis virus or adenovirus vectors, messenger RNA (mRNA), whole inactivated virus, nan…
Factors, enablers and challenges for Covid-19 vaccine development
The COVID-19 pandemic triggered a sense of vulnerability and urgency that led to concerted actions by governments, funders, regulators and industry to overcome traditional challenges for the development of vaccine candidates and to reach authorisation. Unprecedented financial investments, massive demand, accelerated clinical development and regulatory reviews were among the key factors that contributed to accelerating the development and approval…
Assessing vaccine introduction and uptake timelines in Gavi-supported countries
Background Previous studies identified factors influencing regulatory approval to introduction timelines for individual vaccines. However, introduction and uptake timelines have not been comprehensively assessed across the portfolio of Gavi-supported vaccines. Methods We analysed median times between introduction milestones from vaccine licensure to country introduction and uptake across six vaccine-preventable diseases (VPDs), three delivery pla…
Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria
The decision-making process to introduce new vaccines into national immunization programmes is often complex, involving many stakeholders who provide technical information, mobilize finance, implement programmes and garner political support. Stakeholders may have different levels of interest, knowledge and motivations to introduce new vaccines. Lack of consensus on the priority, public health value or feasibility of adding a new vaccine can delay…
Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria
The decision-making process to introduce new vaccines into national immunization programmes is often complex, involving many stakeholders who provide technical information, mobilize finance, implement programmes and garner political support. Stakeholders may have different levels of interest, knowledge and motivations to introduce new vaccines. Lack of consensus on the priority, public health value or feasibility of adding a new vaccine can delay…
Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria
The decision-making process to introduce new vaccines into national immunization programmes is often complex, involving many stakeholders who provide technical information, mobilize finance, implement programmes and garner political support. Stakeholders may have different levels of interest, knowledge and motivations to introduce new vaccines. Lack of consensus on the priority, public health value or feasibility of adding a new vaccine can delay…
Assessing vaccine introduction and uptake timelines in Gavi-supported countries
Background Previous studies identified factors influencing regulatory approval to introduction timelines for individual vaccines. However, introduction and uptake timelines have not been comprehensively assessed across the portfolio of Gavi-supported vaccines. Methods We analysed median times between introduction milestones from vaccine licensure to country introduction and uptake across six vaccine-preventable diseases (VPDs), three delivery pla…
Vaccine access, equity and justice
Although significant progress has been made in achieving goals for COVID-19 vaccine access, the quest for equity and justice remains an unfinished agenda. Vaccine nationalism has prompted calls for new approaches to achieve equitable access and justice not only for vaccines but also for vaccination. This includes ensuring country and community participation in global discussions and that local needs to strengthen health systems, address issues re…
Covid-19 vaccines and the pandemic
Through the experiences gained by accelerating new vaccines for both Ebola virus infection and COVID-19 in a public health emergency, vaccine development has benefited from a ‘multiple shots on goal’ approach to new vaccine targets. This approach embraces simultaneous development of candidates with differing technologies, including, when feasible, vesicular stomatitis virus or adenovirus vectors, messenger RNA (mRNA), whole inactivated virus, nan…
Factors, enablers and challenges for Covid-19 vaccine development
The COVID-19 pandemic triggered a sense of vulnerability and urgency that led to concerted actions by governments, funders, regulators and industry to overcome traditional challenges for the development of vaccine candidates and to reach authorisation. Unprecedented financial investments, massive demand, accelerated clinical development and regulatory reviews were among the key factors that contributed to accelerating the development and approval…
Building and Sustaining Flu Vaccine Acceptance and Trust in the Black Community through Partnerships with Churches, Salons, and Barbershops
Despite the benefits of flu vaccines, Black adults continue to experience lower vaccination rates in the United States. Contributing factors include lack of access to health care and trusted information about vaccines. The National Minority Quality Forum's Center for Sustainable Health Care Quality and Equity collaborated with church pastors, barbers, and hair stylists to disseminate a survey to their communities to assess barriers/facilitators t…
Faith and Flu
Flu vaccination disparities persist among Black adults in the United States, highlighting the need for culturally tailored vaccination promotion strategies. A cross-sectional survey was administered to 159 members of a faith-based health alliance to examine flu vaccine uptake and related influences. Seventy-four percent reported receiving the flu vaccine. Vaccination was associated with older age, health insurance coverage, proactive health behav…
Vaccine Coverage and Hesitancy (7 works) · Business (4 works) · Medicine (4 works) · Political science (4 works) · Vaccination (4 works) · COVID-19 epidemiological studies (3 works) · Public health (3 works) · Public relations (3 works) · Viral Infections and Outbreaks Research (3 works) · Economic growth (2 works)